NCT06576973 2025-12-02Adbelimumab Combined With Chemotherapy and Apatinib in Patients With Resectable Esophageal Squamous Cell CarcinomaSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 2 Recruiting35 enrolled